Download PDF
1 / Pages

Other users also viewed these articles

Does uric acid-lowering treatment slow the progression of chronic kidney disease? A meta-analysis of randomized controlled trials Paulo Roberto Bignardi; Danielle Harumi Ido; Felipe Augusto Lopes Garcia; Lucas Mendes Braga; Vinicius Daher Alvares Delfino;
Nefrologia (English Version). 2023;43:167-81
Colistimethate sodium and acute kidney injury: Incidence, risk factors, outcome and prognosis of renal function Saúl Pampa-Saico; Vicente Pintado; Alfonso Muriel; Fernando Caravaca-Fontan; Estefanía Yerovi-León; Aurora Rojo-Sanchis; José M. del Rey; M. Teresa Tenorio; Fernando Liaño;
Nefrologia (English Version). 2020;40:647-54
Cost-effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalemia in patients with chronic kidney disease or heart failure in Spain Roberto Alcázar-Arroyo; María G Crespo-Leiro; Jordi Bover; Juan Oliva; Miren Sequera-Mutiozabal; Simona Gradari; Anisia Martínez-López; Blanca López-Chicheri; Neus Vidal-Vilar; Susana Aceituno; Marta Cobo;
10.1016/j.nefroe.2024.10.001